US HB5122 | 2015-2016 | 114th Congress
Status
Sponsorship: Strong Partisan Bill (Republican 21-2)
Status: Introduced on April 29 2016 - 25% progression, died in committee
Action: 2016-05-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 29 2016 - 25% progression, died in committee
Action: 2016-05-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models. This bill prohibits the Department of Health and Human Services from taking any further action on a proposed rule to change how Medicare pays for certain drugs that are typically not self-administered (such as some intravenous medications and chemotherapy drugs).
Title
To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
Sponsors
| Rep. Larry Bucshon [R-IN] | Rep. Robert Dold [R-IL] | Rep. Charles Boustany [R-LA] | Rep. Tom Price [R-GA] |
| Rep. John Shimkus [R-IL] | Rep. Brad Ashford [D-NE] | Rep. Tom Reed [R-NY] | Rep. Patrick Tiberi [R-OH] |
| Rep. Erik Paulsen [R-MN] | Rep. Cathy McMorris Rodgers [R-WA] | Rep. Susan Brooks [R-IN] | Rep. Gus Bilirakis [R-FL] |
| Rep. Greg Walden [R-OR] | Rep. Rick Allen [R-GA] | Rep. Robert Latta [R-OH] | Rep. Robert Aderholt [R-AL] |
| Rep. Tom Cole [R-OK] | Rep. John Fleming [R-LA] | Rep. Pete Aguilar [D-CA] | Rep. Leonard Lance [R-NJ] |
| Rep. Barbara Comstock [R-VA] | Rep. Devin Nunes [R-CA] | Rep. Brett Guthrie [R-KY] |
History
| Date | Chamber | Action |
|---|---|---|
| 2016-05-12 | House | Referred to the Subcommittee on Health. |
| 2016-05-06 | House | Referred to the Subcommittee on Health. |
| 2016-04-29 | House | Referred to House Ways and Means |
| 2016-04-29 | House | Referred to House Energy and Commerce |
| 2016-04-29 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2016-04-29 | House | Introduced in House |
Subjects
Administrative law and regulatory procedures
Department of Health and Human Services
Drug therapy
Health
Medicare
Prescription drugs
Department of Health and Human Services
Drug therapy
Health
Medicare
Prescription drugs
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/114th-congress/house-bill/5122/all-info |
| Text | https://www.congress.gov/114/bills/hr5122/BILLS-114hr5122ih.pdf |
